Cleared Traditional

K890058 - VASCULAR TECHNOLOGY UNIOX OXYGEN ALARM

K890058 is an FDA 510(k) clearance for VASCULAR TECHNOLOGY UNIOX OXYGEN ALARM, manufactured by Vascular Technology Incorporated. The device is a Class 2 Anesthesiology device with product code CCL cleared through the Traditional 510(k) pathway after a 319-day FDA review.

K890058 · Vascular Technology Incorporated · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1989
Decision
319d
Days
Class 2
Risk

K890058 is an FDA 510(k) clearance for the VASCULAR TECHNOLOGY UNIOX OXYGEN ALARM. Classified as Analyzer, Gas, Oxygen, Gaseous-phase (product code CCL), Class II - Special Controls.

Submitted by Vascular Technology Incorporated (Chelmsford, US). The FDA issued a Cleared decision on November 21, 1989 after a review of 319 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1720 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vascular Technology Incorporated devices

FDA 510(k) Submission Details - K890058

510(k) Number K890058 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1989
Decision Date November 21, 1989
Days to Decision 319 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
179d slower than avg
Panel avg: 140d · This submission: 319d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCL Device Classification - Class 2, Special Controls

Product Code CCL Analyzer, Gas, Oxygen, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCL Analyzer, Gas, Oxygen, Gaseous-phase

All 57
Devices cleared under the same product code (CCL) and FDA review panel - the closest regulatory comparables to K890058.
BIOCHEM TEMPERATURE/ FIO2 MODULE
K910381 · Biochem International, Inc. · Aug 1991
AG-820PA FI02 MODULE
K896359 · Nihon Kohden America, Inc. · Mar 1990
SPACELABS' MODEL 90514, MULTIGAS ANALYZER
K896427 · Spacelabs, Inc. · Jan 1990
HORIZON 2000 FRACTION OF INSPIRED OXYGEN MON. CAP.
K894918 · Mennen Medical, Inc. · Oct 1989
LOTA, LIFECARE OXYGEN/TEMPERATURE ANALYZER 36-001
K880378 · Lifecare Services, Inc. · Sep 1988
MULTINEX MONITOR (MODIFICATION)
K883254 · Datascope Corp. · Sep 1988